HOLOGIC INC (HOLX)
Healthcare › X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Price History
Feb 9, 2026 — Apr 12, 2026Investment Snapshot
- Trading 112% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 10.4% — below-average profitability
HOLOGIC INC (HOLX) is a Healthcare company operating in X-Ray Apparatus & Tubes & Related Irradiation Apparatus, listed on the NASDAQ , with a market capitalisation of $17.0 billion . Key value metrics: P/E ratio 31.2, P/B ratio 3.24, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
HOLOGIC INC — Fundamental Analysis Summary
HOLOGIC INC (HOLX) is currently trading 112% above its Graham Number of $35.88, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 31.2x.
On financial health, HOLX shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 10.4% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.48.
StockPik's composite Value Score for HOLX is 64/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HOLX reports a solid gross margin of 51.7% (sector average: 40.1%) and a solid operating margin of 17.4%.
HOLX shows revenue growing at 2% year-over-year, with earnings declining at 28%.